Targeting Protein Kinase C Beta II to Reduce Myocardial Ischemia–Reperfusion Injury
Journal of Cardiobiology · 2026
DOI: 10.13188/2332-3671.1000031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiobiology, 2026. Verfasst von Lindon H. Young.
Abstract (Originalsprache)
pressure (LVDP); Left ventricular end-diastolic pressure (LVEDP); Left ventricular end-systolic pressure (LVESP); Mitochondrial permeability transition pore (mPTP); Myocardial infarction (MI); Myocardial ischemia-reperfusion (MIR); Myristic acid (Myr); Myristic acid-and Tat-conjugated PKCβII inhibitor (YT-004); Myristoylated PKCβII activator, N-Myr-SVEIWD (PKCβII+); Myristoylated PKCβII inhibitor, N-Myr-SLNPEWNET (YT-003); Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 (NOX-2); Nitric oxide (NO); Phorbol 12-myristate 13-acetate (PMA); Polymorphonuclear leukocytes (PMNs); Protein kinase C beta II (PKCβII); Rate of decrease in left ventricular pressure (dP/dtmin); Rate of increase in left ventricular pressure (dP/dtmax); Reactive oxygen species (ROS); Receptor for activated C kinase 1 (RACK1); Standard error of the mean (SEM); Superoxide (SO); Trans-activator of transcription peptide (Tat); Tumor necrosis factor-alpha (TNFα)
Zitieren
APA
Young, L. H. (2026). Targeting Protein Kinase C Beta II to Reduce Myocardial Ischemia–Reperfusion Injury. Journal of Cardiobiology. https://doi.org/10.13188/2332-3671.1000031
Vancouver
Young LH. Targeting Protein Kinase C Beta II to Reduce Myocardial Ischemia–Reperfusion Injury. Journal of Cardiobiology. 2026. doi:10.13188/2332-3671.1000031
BibTeX
@article{Young2026,
author = {Young, Lindon H.},
title = {Targeting Protein Kinase C Beta II to Reduce Myocardial Ischemia–Reperfusion Injury},
journal = {Journal of Cardiobiology},
year = {2026},
doi = {10.13188/2332-3671.1000031}
}
EUVIMED